Although Smith+Nephew's overall first quarter revenue has grown since the same period in 2019, orthopedic revenue is still catching up to pre-pandemic figures.
Here's a year-over-year comparison of Smith+Nephew's first-quarter performance in the last three years:
Q1 2021
Revenue: $1.3 billion
Total orthopedic sales: $540 million
Knee sales: $212 million
Hip sales: $154 million
Trauma sales: $149 million
Q1 2020
Revenue: $1.1 billion
Total orthopedic sales: $497 million
Knee sales: $230 million
Hip sales: $137 million
Trauma sales: $109 million
Q1 2019
Net sales: $1.2 billion
Total orthopedic sales: $546 million
Knee sales: $261 million
Hip sales: $152 million
Trauma sales: $119 million